YKL-40 C
Showing 1 - 25 of >10,000
Erectile Dysfunction, Erectile Dysfunction With Diabetes Trial in Aswan (Tadalafil 5mg)
Completed
- Erectile Dysfunction
- Erectile Dysfunction With Diabetes Mellitus
- Tadalafil 5mg
-
Aswan, EgyptAswan university
Jul 5, 2022
YKL -40 as New Biomarker in COVID -19 Patients
Not yet recruiting
- COVID-19
- Computerized Tomography
- (no location specified)
Nov 25, 2021
To Evaluate the Clearance Rate of Uremic Toxin by HFR Trial (HFR)
Not yet recruiting
- To Evaluate the Clearance Rate of Uremic Toxin by HFR
- HFR
- (no location specified)
Aug 15, 2023
Mild Cognitive Impairment Trial in Baltimore (A: 40 Hz music, B: 40 Hz sound, C: Preferred music)
Recruiting
- Mild Cognitive Impairment
- A: 40 Hz music
- +2 more
-
Baltimore, MarylandJohns Hopkins School of Nursing
Dec 6, 2022
Bladder Cancer Trial in Goyang (intravesical mitomycin-C 40mg/20ml instillation)
Completed
- Bladder Cancer
- intravesical mitomycin-C 40mg/20ml instillation
-
Goyang, Korea, Republic ofNational Cancer Center
Jan 30, 2023
Type2 Diabetes Trial (vitamin D, vitamin D )
Enrolling by invitation
- Type2 Diabetes
- vitamin D
- vitamin D placebo
- (no location specified)
Jul 15, 2021
Immune Thrombocytopenic Purpura Trial in Sohag (Genotyping of rs1883832C/T related single-nucleotide polymorphism)
Not yet recruiting
- Immune Thrombocytopenic Purpura
- Genotyping of rs1883832C/T related single-nucleotide polymorphism
-
Sohag, EgyptSohag University hospitals
Oct 16, 2022
Chronic Hepatitis C Trial in Hines (20mg ezetimibe, Placebo, 40mg ezetimibe)
Terminated
- Chronic Hepatitis C
- 20mg ezetimibe
- +2 more
-
Hines, IllinoisEdward Hines Jr. VA Hospital, Hines, IL
May 10, 2022
Leg Ulcer Trial in London, Norwich (geko™ X-W3)
Not yet recruiting
- Leg Ulcer
- geko™ X-W3
-
London, United Kingdom
- +1 more
Oct 10, 2023
Hypercholesterolemia Trial (ezetimibe (+) simvastatin, Comparator: atorvastatin, Comparator: rosuvastatin)
Completed
- Hypercholesterolemia
- ezetimibe (+) simvastatin
- +2 more
- (no location specified)
Feb 7, 2022
C.Delivery; Penetration, Pregnant Uterus, by Instrument, Obesity Trial in Phoenix, Aurora (Randomizing to Suture or Staple
Completed
- C.Delivery; Penetration, Pregnant Uterus, by Instrument
- Obesity
- Randomizing to Suture or Staple closure of Cesarean section
-
Phoenix, Arizona
- +1 more
Aug 24, 2022
Elevated Blood Lead Levels Trial in Mexico City (Lactobacillus plantarum DSM 33464, MegaMetalliQ, Placebo)
Not yet recruiting
- Elevated Blood Lead Levels
- Lactobacillus plantarum DSM 33464, MegaMetalliQ
- Placebo
-
Mexico City, MexicoUniversidad Iberoamericana A.C.
Aug 16, 2022
Platelet Aggregation, Type 2 Diabetes, Aspirin Trial in Montréal (Aspirin 81Mg Ec Tab twice daily for 7 days, Aspirin 40Mg Chew
Not yet recruiting
- Platelet Aggregation
- +4 more
- Aspirin 81Mg Ec Tab twice daily for 7 days
- +2 more
-
Montréal, Quebec, CanadaMontreal Heart Institute
Jan 25, 2023
Hepatitis C, Liver Inflammation, Liver Cirrhoses Trial in Australia (Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet,
Recruiting
- Hepatitis C
- +2 more
- Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet
- Sofosbuvir 400 MG + Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet
-
Randwick, New South Wales, Australia
- +6 more
Mar 28, 2022
Peritoneal Carcinomatosis Trial in Lexington (Mitomycin C, flat dose 40 mg, Mitomycin C, weight-based dose 12.5 mg/m2)
Recruiting
- Peritoneal Carcinomatosis
- Mitomycin C, flat dose 40 mg
- Mitomycin C, weight-based dose 12.5 mg/m2
-
Lexington, KentuckyUniversity of Kentucky
Mar 1, 2022
Healthy Adults Trial in Créteil (Solo 0.3 group, Solo 1 group, Solo 3 group)
Recruiting
- Healthy Adults
- Solo 0.3 group
- +5 more
-
Créteil, France
- +2 more
Sep 9, 2022
Relapsed or Refractory Lymphoma Trial in Miami (Itraconazole 200 mg, Fluconazole 400 mg, Rifampin 600 mg)
Completed
- Relapsed or Refractory Lymphoma
- Itraconazole 200 mg
- +3 more
-
Miami, FloridaQPS- Miami
Jan 12, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +5 more
- Anti-CD40 Agonist Monoclonal Antibody CDX-1140
- +3 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center
Jan 31, 2023
Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Gilteritinib 40 MG Oral Tablet
- +4 more
-
Lexington, KentuckyUniversity of Kentucky
Oct 27, 2022
Child Health Trial in Falun, Karlskrona, Kisa (Partnering for change (P4C-Swe), Treatment as usual)
Recruiting
- Child Health
- Partnering for change (P4C-Swe)
- Treatment as usual
-
Falun, Sweden
- +2 more
Jun 22, 2022
Common Cold, Acute Respiratory Infection, Influenza, Human Trial in Russian Federation (XC8, film-coated tablets, 10 mg,
Recruiting
- Common Cold
- +2 more
- XC8, film-coated tablets, 10 mg
- Placebo
-
Ivanovo, Russian Federation
- +5 more
May 27, 2022